VP, Head of Translational Sciences and Early Development
Biotech
New Haven, Connecticut
Mark Ma is the VP, Head of Translational Clinical Sciences of Rallybio. Prior to Rallybio, Mark had taken several leadership roles at Alexion/AstraZeneca Pharmaceuticals and Amgen Inc, including the head of Bioanalytical and Biomarker Development and the Director of large Molecule Bioanalytical Science. Currently, Mark serves as the co-chair of Bioanalytical Community, AAPS 2021-2022.
Disclosure information not submitted.
Hot Topic: FDA Laboratory Developed Test Proposed Rule and Biomarker Testing
Monday, October 21, 2024
10:00 AM – 11:00 AM MT
Keynote: Bioanalytical Lab in the Era of AI and Revolutionary Technologies
Monday, October 21, 2024
1:30 PM – 2:30 PM MT